Qiuqiong Tang

机构：Insilicos (United States), Suzhou Research Institute, Insilicogen (South Korea) · ORCID：0000-0002-9164-6290

发表论文 17 篇 · 总被引 45 次 · h-index 3

代表论文

• Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies (2022 · Clinical Cancer Research · 被引 18)
• Precious3GPT: Multimodal Multi-Species Multi-Omics Multi-Tissue Transformer for Aging Research and Drug Discovery (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 16)
• AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent (2024 · Aging and Disease · 被引 11)
• NDRG1 expression in cancers confers dependence on DNA damage repair and sensitivity to quinacrine (2026 · Science Signaling)
• NDRG1 expression in cancers confers dependence on DNA damage repair and sensitivity to quinacrine (2026 · DRYAD)
• AI-aided identification of dual-purpose therapeutic targets PRPF19 and MAPK9 in hepatocellular carcinoma and cellular senescence (2025 · npj Aging)